Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
Clinical trial NCT00276302 · COMPLETED
Trial details
- NCT number
- NCT00276302
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2010-11-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.